172 / 464
172
POSTERS AND ELECTRONIC POSTERS
| Programme and Exhibition Guide
POSTERS
M. Seiz-Rosenhagen, C. Groden, P. Schmiedek, M. Glas, D. Hänggi,
K. Petrecca
PO-0632
> Randomized study of adjuvant temozolomide (6 vs.12 cycle) in newly
diagnosed glioblastoma multiforme
A.K. Gandhi (India), M. Bhandari, D.N. Sharma, P. Julka, G.K. Rath
PO-0633
> Irradiation of Subventricular Zone in Glioblastoma: Its Impact on
Tumor Progression and Survival
F. Sert (Turkey), S. Hoca, S. Kamer, Y. Anacak
PO-0634
> Can psychological support during RT improve distress, mood or quality
of life in CNS tumor patients?
L. Dinapoli, S. Chiesa (Italy), N. Dinapoli, F. Beghella Bartoli, S. Bracci,
M. Massaccesi, A. Tenore, A. Pesce, V. Valentini, M. Balducci
PO-0635
> Impact of DWI-MRI for gross tumor volume definition in patients with
recurrent glioblastoma
O. Oehlke (Germany), S. Bott, A.L. Grosu, I. Mader
PO-0636
> HFSRT to the resection bed for intracranial metastases: a large
retrospective study of 181 patients.
A. Keller (France), M. Doré, F. Thillays, F. Proust, H. Cebula, I. Darié,
F. Lefebvre, G. Noel, D. Antoni
PO-0637
> FET PET prior to primary RT of glioblastoma patients - a recurrence
pattern analysis
D.F. Fleischmann (Germany), M. Unterrainer, R. Schön, S. Corradini,
C. Maihöfer, P. Bartenstein, C. Belka, N.L. Albert, M. Niyazi
PO-0638
> Feasibility of tract based dosimetric analysis in brain tumor patients
M. Conson (Italy), L. Cella, E. D’Ippolito, F. Piccolo, S. Cocozza,
V. D’Avino, R. Liuzzi, M. Quarantelli, R. Pacelli
PO-0639
> Which measurement type should be used for disease control of brain
metastasis, volumetric or linear?
A. Fischedick, G. Fischedick (Germany), U. Haverkamp
PO-0640
> A novel voxel based homogeneity index: clinical implications for WBRT
A.H. Thieme (Germany), C. Stromberger, P. Ghadjar, A. Grün,
S. Zschaek, V. Budach
PO-0641